Welcome to our dedicated page for Caleres SEC filings (Ticker: CAL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Caleres Inc. filings document the footwear company’s operating results, governance matters, executive-officer changes and capital-structure disclosures. Its Form 8-K reports include quarterly results furnished under Item 2.02 and leadership disclosures under Item 5.02, including principal financial and accounting officer appointments and departures.
Proxy materials cover annual meeting governance topics, board matters and executive compensation disclosures for the company. Filing records also identify Caleres common stock, par value $0.01 per share, listed on the New York Stock Exchange under the symbol CAL, along with material-event, material-agreement and capital-structure reporting relevant to the company’s public-company status.
Welter Kathleen K reported acquisition or exercise transactions in this Form 4 filing.
Caleres Inc. senior vice president and Chief HR Officer Kathleen K. Welter received a grant of 19,055 shares of restricted common stock at no cash cost. The restricted stock vests 50% after 2 years and 50% after 3 years. Following this equity award, she directly holds 38,498 Caleres shares.
Costello Brian P reported acquisition or exercise transactions in this Form 4 filing.
CALERES INC divisional president Brian P. Costello reported an equity award of 21,037 shares of common stock as compensation. The award is structured as restricted stock that vests 50% after 2 years and 50% after 3 years. Following this grant, Costello directly holds 45,641 common shares.
Freidman Daniel R reported acquisition or exercise transactions in this Form 4 filing.
CALERES INC Chief Sourcing Officer Daniel R. Freidman reported a new equity award of company stock. On June 8, 2026, he received a grant of 22,866 shares of common stock at no cash cost as a compensation-related award, not an open‑market purchase.
According to the filing, this restricted stock vests in stages, with 50% vesting after two years and the remaining 50% after three years. After this grant, Freidman holds 87,646 shares directly and an additional 7,457 shares indirectly through a 401(k) plan, aligning a portion of his compensation with Caleres’ stock performance over time.
Burke Thomas C reported acquisition or exercise transactions in this Form 4 filing.
CALERES INC SVP and General Counsel Thomas C. Burke received a grant of 21,037 shares of common stock as a compensation-related award. According to the footnote, this restricted stock vests 50% after 2 years and 50% after 3 years.
Following the grant, Burke directly holds 87,448 common shares and indirectly holds 8,458 shares through a 401(k) plan. The award was priced at $0.00 per share, reflecting a non-cash equity grant rather than an open-market purchase.
Schmidt John W reported acquisition or exercise transactions in this Form 4 filing.
CALERES INC President & CEO John W. Schmidt reported a new equity grant and updated holdings of company stock. On June 8, 2026, he received a grant of 190,549 shares of common stock at no purchase price as a compensation-related award. According to the filing, this restricted stock vests 50% after two years and 50% after three years.
Following the grant, Schmidt directly holds 605,389 shares of CALERES INC common stock. The filing also lists indirect holdings of 6,089 shares through a 401(k) plan and 2,500 shares held by his spouse, reflecting additional beneficial ownership outside the new grant.
Karpel Daniel L reported acquisition or exercise transactions in this Form 4 filing.
CALERES INC reported that SVP and Chief Financial Officer Daniel L. Karpel received two restricted stock grants of common stock on June 8, 2026. One award covered 11,433 shares that vest 50% after two years and 50% after three years. The second award covered 15,244 shares, vesting in three equal annual installments. These are compensation-related equity awards granted at no cash cost per share, and the filing lists updated direct holdings figures of 50,876 and 39,443 common shares following the respective grants.
Caleres Inc. Chief Information Officer Willis Hill reported a new equity award rather than an open-market trade. He received a grant of 21,037 shares of common stock at $0.00 per share as compensation, classified as a grant or award acquisition. According to the footnote, this restricted stock vests 50% after two years and 50% after three years. Following the grant, Hill directly holds 77,791.643 shares of Caleres common stock, with an additional 3,673 shares held indirectly through a 401(k) plan. The filing shows no open-market buying or selling activity.
Flavin Lisa reported acquisition or exercise transactions in this Form 4 filing.
Caleres Inc. director Lisa Flavin received a grant of 12,196 restricted stock units as equity compensation. Each unit represents the fair market value of one share of Caleres common stock and will be settled in shares when her board service ends or on another elected date.
The units vest only if she continues serving as a director through the next annual meeting of shareholders. After this award, she holds 12,196 restricted stock units directly, and there were no open-market stock purchases or sales reported.
Gupta Mahendra R reported acquisition or exercise transactions in this Form 4 filing.
CALERES INC director Mahendra R. Gupta received a stock grant of company shares as part of his board compensation. He was awarded 12,196 shares of common stock at a reference value of $13.12 per share, bringing his direct holdings to 51,336 shares after the transaction.
The award consists of restricted stock that will vest only if he continues serving as a director through the next annual meeting of shareholders, aligning his incentives with long-term company performance rather than being an open-market purchase.
LANGENSTEIN MOLLY reported acquisition or exercise transactions in this Form 4 filing.
CALERES INC director Molly Langenstein received an equity grant of 12,196 shares of Common Stock valued at $13.12 per share. The transaction is classified as a grant or award, not an open-market purchase, and increases her direct holdings to 35,306 shares.
The vesting of this restricted stock is contingent on her continued service as a director through the next annual meeting of shareholders, so the award is tied to ongoing board service and functions as routine equity-based compensation.